| HC_1 | HC | 1 | 35 | male | 178 | 64 | | | | | | | | | | | | | | | | | |
| HC_2 | HC | 2 | 32 | female | 172 | 71.7 | | | | | | | | | | | | | | | | | |
| HC_3 | HC | 3 | 36 | female | 163 | 88 | | | | | | | | | | | | | | | | | |
| HC_4 | HC | 4 | 35 | male | 180 | 86.9 | | | | | | | | | | | | | | | | | |
| HC_5 | HC | 5 | 22 | female | 161 | 65.5 | | | | | | | | | | | | | | | | | |
| HC_6 | HC | 6 | 22 | female | 160 | 63 | | | | | | | | | | | | | | | | | |
| HC_7 | HC | 7 | 22 | male | 181 | 60 | | | | | | | | | | | | | | | | | |
| HC_8 | HC | 8 | 22 | female | 163 | 67.1 | | | | | | | | | | | | | | | | | |
| HC_9 | HC | 9 | 25 | male | 170 | 70.4 | | | | | | | | | | | | | | | | | |
| HC_10 | HC | 10 | 23 | male | 179 | 87 | | | | | | | | | | | | | | | | | |
| HC_11 | HC | 11 | 22 | female | 171 | 65.6 | | | | | | | | | | | | | | | | | |
| HC_12 | HC | 12 | 24 | female | 163 | 55.7 | | | | | | | | | | | | | | | | | |
| HC_13 | HC | 13 | 24 | male | 184 | 89 | | | | | | | | | | | | | | | | | |
| HC_14 | HC | 14 | 43 | female | 160 | 90 | | | | | | | | | | | | | | | | | |
| HC_15 | HC | 15 | 26 | female | 165 | 55 | | | | | | | | | | | | | | | | | |
| HC_16 | HC | 16 | 22 | female | 154 | 58.7 | | | | | | | | | | | | | | | | | |
| HC_17 | HC | 17 | 55 | male | 167 | 57.2 | | | | | | | | | | | | | | | | | |
| HC_18 | HC | 18 | 51 | female | 162 | 70.04 | | | | | | | | | | | | | | | | | |
| HC_19 | HC | 19 | 22 | female | 160 | 45 | | | | | | | | | | | | | | | | | |
| HC_20 | HC | 20 | 22 | male | 173 | 77.6 | | | | | | | | | | | | | | | | | |
| HC_21 | HC | 21 | 27 | female | 164 | 47 | | | | | | | | | | | | | | | | | |
| HC_22 | HC | 22 | 28 | female | 170 | 77 | | | | | | | | | | | | | | | | | |
| HC_23 | HC | 23 | 19 | female | 163 | 48.9 | | | | | | | | | | | | | | | | | |
| HC_24 | HC | 24 | 20 | male | 167 | 61 | | | | | | | | | | | | | | | | | |
| HC_25 | HC | 25 | 23 | female | 160 | 50.4 | | | | | | | | | | | | | | | | | |
| HC_26 | HC | 26 | 20 | male | 187 | 68.9 | | | | | | | | | | | | | | | | | |
| HC_27 | HC | 27 | 19 | female | 163 | 51 | | | | | | | | | | | | | | | | | |
| HC_28 | HC | 28 | 23 | male | 178 | 96.6 | | | | | | | | | | | | | | | | | |
| HC_29 | HC | 29 | 57 | male | 188 | 106 | | | | | | | | | | | | | | | | | |
| HC_30 | HC | 30 | 33 | male | 179 | 80.4 | | | | | | | | | | | | | | | | | |
| HC_31 | HC | 31 | 32 | female | 168 | 61.9 | | | | | | | | | | | | | | | | | |
| HC_32 | HC | 32 | 30 | male | 188 | 110.2 | | | | | | | | | | | | | | | | | |
| HC_33 | HC | 33 | 22 | male | 185 | 112.4 | | | | | | | | | | | | | | | | | |
| HC_34 | HC | 34 | 21 | male | 175 | 72.6 | | | | | | | | | | | | | | | | | |
| HC_35 | HC | 35 | 22 | female | 157 | 47.6 | | | | | | | | | | | | | | | | | |
| HC_36 | HC | 36 | 21 | male | 170 | 71 | | | | | | | | | | | | | | | | | |
| HC_37 | HC | 37 | 21 | male | 180 | 67.5 | | | | | | | | | | | | | | | | | |
| HC_38 | HC | 38 | 19 | male | 178 | 83 | | | | | | | | | | | | | | | | | |
| HC_39 | HC | 39 | 24 | male | 175 | 85 | | | | | | | | | | | | | | | | | |
| HC_40 | HC | 40 | 22 | male | 181 | 79 | | | | | | | | | | | | | | | | | |
| HC_41 | HC | 41 | 25 | female | 173 | 65 | | | | | | | | | | | | | | | | | |
| HC_42 | HC | 42 | 37 | female | 168 | 70 | | | | | | | | | | | | | | | | | |
| HFC_148 | HFC | 148 | 57 | male | 180 | 90.5 | absent | absent | absent | absent | absent | absent | NOT FOUND | 25.00% | NOT FOUND | NOT FOUND | NOT FOUND | N/A | Metoprolol | 62.5 twice daily | Ramipril | Furosemide | 40 twice daily |
| HFC_147 | HFC | 147 | 61 | female | 163 | 111 | absent | present | absent | absent | present | absent | Idiopathic cardiomyopathy | 51.00% | 2 | NOT FOUND | absent | Apixaban | N/A | N/A | N/A | N/A | N/A |
| HFC_129 | HFC | 129 | 62 | male | 184 | 101 | absent | absent | absent | present | present | present | Idiopathic cardiomyopathy | NOT FOUND | 2 | NOT FOUND | absent | Warfarin | Metoprolol | 50 | N/A | Furosemide | 40 |
| HFC_142 | HFC | 142 | 67 | female | 150 | 81 | absent | present | absent | present | absent | absent | Idiopathic cardiomyopathy | 53.00% | 2 | NOT FOUND | absent | Apixaban | Bisoprolol | 2.5 | N/A | N/A | N/A |
| HFC_134 | HFC | 134 | 56 | female | 166 | 71 | absent | absent | absent | absent | absent | absent | Idiopathic cardiomyopathy | 54.00% | 1 | absent | absent | N/A | Bisoprolol | 5 | N/A | N/A | N/A |
| HFC_139 | HFC | 139 | 39 | male | 168 | 72 | absent | absent | absent | absent | present | absent | Ischaemic heart disease | 33.00% | 1 | NOT FOUND | absent | Apixaban | Carvedilol | 18.75 | N/A | N/A | N/A |
| HFC_121 | HFC | 121 | 21 | male | 158 | 64 | absent | absent | absent | absent | absent | absent | Idiopathic cardiomyopathy | 45.00% | 1 | NOT FOUND | absent | N/A | N/A | N/A | N/A | N/A | N/A |
| HFC_106 | HFC | 106 | 34 | male | 175 | 77 | present | absent | absent | present | absent | absent | Idiopathic cardiomyopathy | 27.00% | 1 | NOT FOUND | absent | Apixaban | Bisoprolol | 1.25 | N/A | N/A | N/A |
| HFC_103 | HFC | 103 | 59 | male | 173 | 70 | absent | absent | absent | absent | absent | present | Idiopathic cardiomyopathy | 21.00% | 3 | NOT FOUND | absent | Apixaban | Bisoprolol | 5 | N/A | N/A | N/A |
| HFC_145 | HFC | 145 | 48 | male | 165 | 141 | absent | absent | absent | present | present | present | Idiopathic cardiomyopathy | 49.00% | 4 | NOT FOUND | absent | N/A | Carvedilol | 25 | N/A | N/A | N/A |
| HFC_144 | HFC | 144 | 63 | male | 160 | 69 | NOT FOUND | absent | absent | present | present | NOT FOUND | Idiopathic cardiomyopathy | 17.00% | 2 | NOT FOUND | absent | Edoxaban | Bisoprolol | 7.5 twice daily | N/A | Furosemide | 20 |
| HFC_114 | HFC | 114 | 31 | male | 194 | 96 | absent | absent | absent | absent | absent | absent | Other (familial cardiomyopathy) | 49.00% | 1 | NOT FOUND | absent | N/A | Bisoprolol | N/A | N/A | N/A | N/A |
| HFC_117 | HFC | 117 | 28 | male | 163 | 67.1 | absent | absent | absent | absent | present | absent | Other (hypertrophic cardiomyopathy) | 55.00% | 3 | NOT FOUND | absent | N/A | Bisoprolol | 10 | N/A | N/A | N/A |
| HFC_108 | HFC | 108 | 79 | male | 184 | 92.5 | absent | absent | absent | present | present | absent | Other (cardiac sarcoid) | 39.00% | 1 | NOT FOUND | absent | Apixaban | Carvedilol | 50 | Ramipril | N/A | N/A |
| HFC_111 | HFC | 111 | 61 | female | 170 | 105.5 | absent | present | present | present | present | present | Other (cardiac sarcoid) | 30.00% | 1 | NOT FOUND | absent | Rivaroxoban | Carvedilol | 65 | Sacubitril-valsartan, spironolactone | Furosemide | 20 |
| HFC_131 | HFC | 131 | 68 | female | 169 | 71 | absent | absent | absent | present | absent | absent | Other (non-ischemic cardiomyopathy) | 52% | 1 | NOT FOUND | absent | Apixaban | Bisoprolol | 10 | Sacubitril-valsartan, spironolactone | N/A | N/A |
| HFC_146 | HFC | 146 | 48 | male | 183 | 96 | absent | absent | absent | present | absent | absent | Other (non-ischemic cardiomyopathy) | 25.00% | 1 | NOT FOUND | absent | Apixaban | Bisoprolol | 7.5 | Sacubitril-valsartan, spironolactone | N/A | N/A |
| HFC_101 | HFC | 101 | 39 | female | 162 | 67.9 | absent | absent | absent | absent | present | absent | Other (non-ischemic cardiomyopathy) | 42.00% | 1 | NOT FOUND | absent | N/A | N/A | 160 | Sacubitril-valsartan, Spironolactone | N/A | N/A |
| HFC_132 | HFC | 132 | 62 | male | 178 | 88.3 | present | present | present | present | present | present | Ischaemic heart disease | 28.00% | 2 | NOT FOUND | absent | Apixaban | Bisoprolol | 10 | Spironolactone, sacubitril-valsartan | Furosemide | 20 |
| HFC_133 | HFC | 133 | 49 | male | 167 | 110 | absent | present | present | absent | absent | absent | Other (nonischemic cardiomyopathy) | 62.00% | 1 | NOT FOUND | absent | N/A | Bisoprolol | 10 | Sacubitril-valsartan | Furosemide | 20 |
| HFC_110 | HFC | 110 | 55 | female | 155 | 67 | absent | present | absent | absent | absent | absent | Other | 58.00% | 2 | NOT FOUND | absent | N/A | Bisoprolol | 5 | Ramipril, spironolactone | Furosemide | 160 |
| HFC_102 | HFC | 102 | 54 | male | 180 | 94.6 | absent | absent | absent | absent | absent | absent | Idiopathic cardiomyopathy | 50.00% | 1 | NOT FOUND | absent | N/A | Bisoprolol | 5 | Candesartan, spironolactone | N/A | N/A |
| HFC_124 | HFC | 124 | 33 | male | 172 | 78.5 | absent | absent | present | absent | absent | absent | Ischaemic heart disease | 38.00% | 1 | NOT FOUND | absent | N/A | Bisoprolol | 15 | Sacubitril-valsartan | Furosemide | 20 |
| HFC_126 | HFC | 126 | 75 | male | 174 | 77 | absent | absent | absent | present | absent | absent | NOT FOUND | 24.00% | NOT FOUND | absent | absent | N/A | Bisoprolol | | N/A | N/A | |
| HFC_116 | HFC | 116 | 60 | male | 178 | 62 | absent | present | absent | absent | absent | absent | NOT FOUND | 39.00% | 1 | absent | absent | N/A | Carvedilol | | N/A | Furosemide | 20 |
| HFC_118 | HFC | 118 | 57 | male | 149 | 44.5 | present | absent | present | absent | absent | absent | Ischaemic heart disease | 34.00% | 2 | absent | present | Apixaban | Bisoprolol | 10 | Sacubitril/valsartan, sprinolactone | Furosemide | 40 |
| HFC_141 | HFC | 141 | 29 | male | 174 | 92 | absent | absent | absent | absent | absent | absent | Other – Other (dilated cardiomyopathy) | NOT FOUND | 2 | absent | absent | N/A | Bisoprolol | 10 | Spironolactone, sacubitril-valsartan | Furosemide | 40 |
| HFC_149 | HFC | 149 | 39 | female | 170 | 64 | absent | present | present | present | present | absent | Other (dilated cardiomyopathy) | 27.00% | 3 | present | absent | N/A | Bisoprolol | 1.25 | Spironolactone, sacubitril-valsartan | N/A | N/A |